Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
6
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
6
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
gene therapy
novartis
alzheimer's disease
amgen
biogen
cancer
cancer immunotherapy
eli lilly
fda
gilead sciences
What
bio
roundup
abbvie’s
companies
day
days
drug
labor
news
opioid
acquisitions
ahead
albert
approval
august
barbecuing
biggest
biofourmis
biogen’s
biopharmaceutical
biotech
black
bourla
bucks
busy
camping
cancer
cardiologist
celebrate
center
ceo
chance
check
cholesterol
company
conference
continue
convo
corner
crispr
Language
unset
unknown
Current search:
abbvie
×
" new york blog main "
×
glaxosmithkline
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More